Ossdsign AB (Publ) reported revenues for the period October - November 2023. For the period, company reported Preliminary total revenues amount to SEK 25.2 million, mainly attributable to a continued strong market performance of the orthobiologics franchise and some extraordinary orders from a large hospital system. According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to SEK 18.8 million during the period of October - November 2023, whereas OssDsign Cranial recorded sales of SEK 6.4 million.